Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
My Portfolio
Codere Online Luxembourg, S.A. - Ordinary Shares
(NQ:
CDRO
)
8.680
+0.005 (+0.06%)
Delayed Quote
Updated: 3:48 PM EST, Nov 12, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Codere Online Luxembourg, S.A. - Ordinary Shares
< Previous
1
2
3
4
Next >
Hedge Fund Tiger Legatus Is Shutting Down. It Was Betting Big on These 10 Stocks.
↗
June 15, 2022
After 13 years, Tiger Legatus will officially shut down. The fund owns 12 names in its portfolio, including UBER and DKNG stocks.
Via
InvestorPlace
Mid-Morning Market Update: Markets Open Lower; US Jobless Claims Increase To 218,000
↗
May 19, 2022
U.S. stocks traded lower this morning, with the Dow Jones dipping more than 300 points on Thursday.
Via
Benzinga
Earnings Scheduled For May 13, 2022
↗
May 13, 2022
Companies Reporting Before The Bell • Codere Online Luxembourg (NASDAQ:CDRO) is estimated to report quarterly loss at $0.13 per share on revenue of $20.08 million.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
↗
February 08, 2022
Tuesday's session saw 109 companies set new 52-week lows. Interesting Points From Today's 52-Week Highs And Lows: The largest company in terms of market cap...
Via
Benzinga
Mid-Day Market Update: Dow Drops 100 Points; U.S. Nonfarm Payrolls Top Estimates
↗
February 04, 2022
US stocks traded mixed on Friday after Amazon.com, Inc. (NASDAQ: AMZN) reported better-than-expected earnings for its fourth quarter.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 4, 2022
↗
January 04, 2022
Upgrades According to Vertical Research, the prior rating for Livent Corp (NYSE:
Via
Benzinga
61 Biggest Movers From Yesterday
↗
January 04, 2022
Gainers Genprex, Inc. (NASDAQ: GNPX) shares surged 167.2% to settle at $3.50 on Monday. The FDA granted Fast Track Designation for Genprex’s lead drug candidate, Reqorsa...
Via
Benzinga
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.